Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men
NCT ID: NCT00846599
Last Updated: 2017-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2008-01-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
High omega-3
Omega-3 study meal
Participant will eat a study meal high in omega-3 fatty acids.
2
High saturated fat
Saturated fat study meal
Participant will eat a study meal high in saturated fat.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Omega-3 study meal
Participant will eat a study meal high in omega-3 fatty acids.
Saturated fat study meal
Participant will eat a study meal high in saturated fat.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Under one of the following treatment categories:
* Treatment naive or have never taken any HIV medications
* Taking Kaletra
* Taking Sustiva
* Taking Atripla
Exclusion Criteria
* Pre-existing diagnosis or treatment for the following:
* Lipid disorder
* Cardiovascular disease
* High blood pressure
* Diabetes
* Acute opportunistic infection or malignancy within last 3 months or current therapy for either
* Active IV drug use
18 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tufts University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tufts University School of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandra Mangili, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Tufts University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tufts University
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SUB730
Identifier Type: -
Identifier Source: org_study_id